MedTrace Logo

Usefulness of the Artery First Approach in Pancreatic Cancer Surgery

NCT04136522 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 268

Last updated 2022-07-20

No results posted yet for this study

Summary

This study is aimed to evaluate difference of the 2 year recurrence free survival after pancreaticoduodenectomy for pancreatic cancer between artery-first approach and conventional procedure groups.

Conditions

  • Pancreatic Cancer, Adult
  • Margin, Tumor-Free
  • Surgery Site Fistula
  • Recurrence Tumor

Interventions

PROCEDURE

conventional pancreaticoduodenectomy

In this subgroup, the surgeon will perform pancreaticoduodenectomy without isolation of superior mesenteric artery and dissection of nerve plexus and lymph node around superior mesenteric artery.

PROCEDURE

total mesopancreas excision including superior mesenteric artery first approach

In this subgroup, the surgeon will identify and isolate superior mesenteric artery before pancreatic transection, they dissect soft tissues including nerve plexus and node around superior mesenteric artery.

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Song-Cheol Kim, MD.PhD · Asan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-10
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04136522 on ClinicalTrials.gov